Ghosts in the machine: Comment on Sismondo

Social Studies of Science

Volumn 39, Issue 6, 2009, Pages 943-947

  McHenry, Leemon ^a  

^a CALIFORNIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70450210219     PISSN: 03063127     EISSN: 14603659     Source Type: Journal    
DOI: 10.1177/0306312709345358     Document Type: Note

References (14)

1. Elliott, Carl (2004) Pharma Goes to the Laundry: Public Relations and the Business of Medical Education, Hastings Center Report 34: 18-23.
2. Graham, David J., David Campen, Rita Hui, Michele Spence, Craig Cheetham, Gerald Levy, Stanford Shoor & Wayne A. Ray (2005) Risk of Acute Mycardial Infarction and Sudden Cardiac Death in Patients Treated with Cyclo-oxygenase 2 Selective and Non-selective Non-steroidal Anti-inflammatory Drugs: Nested Case-Control Study, The Lancet 365: 475-81.
3. Healy, David (2008) Our Censored Journals, Mens Sana Monographs 6: 244-56.
4. Holden, C. (2006) Scientific Publishing: The Undisclosed Background of a Paper on a Depression Treatment, Science, 313: 598-99.
5. Jureidini, Jon, Leemon McHenry & Peter Mansfield (2008) Clinical Trials and Drug Promotion: Selective Reporting of Study 329, International Journal of Risk & Safety in Medicine 20: 73-81.
6. Krimsky, Sheldon (2003) Science in the Private Interest (Lanham, MD: Roman & Littlefield).
7. Kuhn, Thomas (1962) The Structure of Scientific Revolutions (Chicago, IL: University of Chicago Press).
8. McHenry, Leemon (2005) On the Origin of Great Ideas: Science in the Age of Big Pharma, Hastings Center Report 35: 17-19.
9. McHenry, Leemon & Jon Jureidini (2008) Industry-sponsored Ghostwriting in Clinical Trial Reporting: A Case Study, Accountability in Research 15(3): 152-67.
10. Popper, Karl (1959) The Logic of Scientific Discovery (New York: Basic Books).
11. Ross, Joseph S., Kevin P. Hill, David S. Egliman & Harlan M. Krumholz (2008) Guest Authorship and Ghostwriting in Publications Related to Rofecoxib: A Case Study of Industry Documents From Rofecoxib Litigation, Journal of the American Medical Association 299(15):1800-12.
12. Sismondo, Sergio (2009) Ghosts in the Machine: Publication Planning in the Medical Sciences, Social Studies of Science 39(2): 171-98.
13. Sismondo, Sergio & Mathieu Doucet (2009) Publication Ethics and the Ghost Management of Medical Publication, Bioethics DOI 10.1111/j.1467-8519. 2008.01702.x.
14. Steinman, Michael A., Lisa A. Bero, Mary-Margaret Chren & C. Seth Landefeld (2006) Narrative Review: The Promotion of Gabapentin: An Analysis of Internal Industry Documents, Annals of Internal Medicine 145: 284-93.